JAMAICA PROMOTIONS CORPORATION (JAMPRO) ANNOUNCES A MAJOR PHARMACEUTICAL PARTNERSHIP BETWEEN PURE JAMAICAN AND SWEDEN’S KLARIA PHARMA

THE PURE JAMAICAN GROUP OF COMPANIES AND KLARIA PHARMA WILL CONDUCT ACCELERATED R&D IN JAMAICA AND LAUNCH A NEW PHARMACEUTICAL DELIVERY SYSTEM FOR PSILOCYBIN, TO SUPPORT GLOBAL ADVANCEMENTS IN MENTAL HEALTH SCIENCE

July 14, 2021 – Montego Bay, Jamaica and Stockholm, Sweden – The Pure Jamaican Group of Companies (Pure Jamaican), including the pharmaceutical division Seven-10 based in Montego Bay, and Klaria Pharma Holding AB (Klaria), a Swedish pharmaceutical firm listed on NASDAQ First North (KLAR.ST), announced today that they have established an exclusive agreement to conduct R&D and to commercialize their offerings, across all of the LAC region (Latin America and Caribbean Region, which is defined as Mexico, Central America, South America and the Caribbean). The ground-breaking offering is a patented revolutionary, pharmaceutical, precision-dose delivery system for psilocybin to support global advancements in mental health science. 
 

For more information, please see the attached full Press Release.

Download as PDF